Frequency of BRCA1 (185delAG and 5382insC) and BRCA2 (6174delT) mutations in Egyptian women with breast cancer compared to healthy controls-Reference-Cited by-同舟云学术

Frequency of BRCA1 (185delAG and 5382insC) and BRCA2 (6174delT) mutations in Egyptian women with breast cancer compared to healthy controls

Published:2018-02 Issue: Volume:15 Page:35-41
ISSN:2214-5400
Container-title:Meta Gene
language:en
Short-container-title:Meta Gene

Author:

Abou-El-Naga Amoura,Shaban Ahmed,Ghazy Hayam,Elsaid Afaf,Elshazli Rami^ORCID,Settin Ahmad

Publisher

Elsevier BV

Subject

Genetics(clinical),Genetics

Reference63 articles.

1. BRCA1 gene mutations and influence of chemotherapy on autophagy and apoptotic mechanisms in Egyptian breast cancer patients;Abdel-Mohsen;Asian Pac. J. Cancer Prev.,2016

2. The founder mutations 185delAG and 5382insC in BRCA1 and 6174delT in BRCA2 appear in 60% of ovarian cancer and 30% of early-onset breast cancer patients among Ashkenazi women;Abeliovich;Am. J. Hum. Genet.,1997

3. Prevalence of BRCA1 and BRCA2 mutations in unselected breast cancer patients from Peru;Abugattas;Clin. Genet.,2015

4. Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case series unselected for family history: a combined analysis of 22 studies;Antoniou;Am. J. Hum. Genet.,2003

5. Log odds of carrying an ancestral mutation in BRCA1 or BRCA2 for a defined personal and family history in an Ashkenazi Jewish woman (LAMBDA);Apicella;Breast Cancer Res.,2003

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. BRCA mutations: screening for germ-line founder mutations among early-onset Syrian breast cancer patients;Egyptian Journal of Medical Human Genetics;2024-02-08

2. The Landscape of BRCA Mutations among Egyptian Women with Breast Cancer;Oncology and Therapy;2023-09-20

3. Association of GSTP1 p.Ile105Val (rs1695, c.313A > G) Variant with the Risk of Breast Carcinoma among Egyptian Women;Biochemical Genetics;2021-05-03

4. Signal peptide missense variant in cancer-brake gene CTLA4 and breast cancer outcomes;Gene;2020-05

5. Nobiletin inhibits breast cancer via p38 mitogen-activated protein kinase, nuclear transcription factor-κB, and nuclear factor erythroid 2-related factor 2 pathways in MCF-7 cells;Food & Nutrition Research;2018-11-21